Placental stem cells are cells derived from the placental blood and other body fluids of a new-born baby. Stem cells are human cells classified into a different variety of cell types, including brain and muscle cells. Stem cells are sometimes used in the development of regenerative therapies. Regenerative medicine represents a category of scientific alternatives to stem cell therapy (such as tissue regeneration). These treatments include the capacity to regenerate human cells, tissues, or organs to return the body to healthy working. Stem cell therapies are used to cure and improve diseases like spinal cord injuries, Parkinson's disease, heart disease, and diabetes.
Market Analysis and Insights: Global Placental Stem Cell Therapy Market
The global Placental Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Placental Stem Cell Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Placental Stem Cell Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Placental Stem Cell Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Placental Stem Cell Therapy market.
Placental Stem Cell Therapy Breakdown Data by Type
Hematologic Malignancies and Disorders
Congenital Immunodeficiency Disorders
Metabolic Disorders
Neurological Disorders
Others
Placental Stem Cell Therapy Breakdown Data by Application
Hospitals and Specialty Clinics
Clinical Research Organizations
Research Institutes and Academies
Others
Based on regional and country-level analysis, the Placental Stem Cell Therapy market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Placental Stem Cell Therapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.
The following players are covered in this report:
Lifebank Stem Cell Banking
Cynata
Celularity
Athersys
Americord Registry
ReNeuron Group
ReeLabs
Mesoblast
Pluristem Therapeutics
Market Analysis and Insights: Global Placental Stem Cell Therapy Market
The global Placental Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Placental Stem Cell Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Placental Stem Cell Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Placental Stem Cell Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Placental Stem Cell Therapy market.
Placental Stem Cell Therapy Breakdown Data by Type
Hematologic Malignancies and Disorders
Congenital Immunodeficiency Disorders
Metabolic Disorders
Neurological Disorders
Others
Placental Stem Cell Therapy Breakdown Data by Application
Hospitals and Specialty Clinics
Clinical Research Organizations
Research Institutes and Academies
Others
Based on regional and country-level analysis, the Placental Stem Cell Therapy market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Placental Stem Cell Therapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.
The following players are covered in this report:
Lifebank Stem Cell Banking
Cynata
Celularity
Athersys
Americord Registry
ReNeuron Group
ReeLabs
Mesoblast
Pluristem Therapeutics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Placental Stem Cell Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hematologic Malignancies and Disorders
1.2.3 Congenital Immunodeficiency Disorders
1.2.4 Metabolic Disorders
1.2.5 Neurological Disorders
1.2.6 Others
1.3 Market by Application
1.3.1 Global Placental Stem Cell Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and Specialty Clinics
1.3.3 Clinical Research Organizations
1.3.4 Research Institutes and Academies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Placental Stem Cell Therapy Market Perspective (2016-2027)
2.2 Placental Stem Cell Therapy Growth Trends by Regions
2.2.1 Placental Stem Cell Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Placental Stem Cell Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Placental Stem Cell Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Placental Stem Cell Therapy Industry Dynamic
2.3.1 Placental Stem Cell Therapy Market Trends
2.3.2 Placental Stem Cell Therapy Market Drivers
2.3.3 Placental Stem Cell Therapy Market Challenges
2.3.4 Placental Stem Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Placental Stem Cell Therapy Players by Revenue
3.1.1 Global Top Placental Stem Cell Therapy Players by Revenue (2016-2021)
3.1.2 Global Placental Stem Cell Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Placental Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Placental Stem Cell Therapy Revenue
3.4 Global Placental Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Placental Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Placental Stem Cell Therapy Revenue in 2020
3.5 Placental Stem Cell Therapy Key Players Head office and Area Served
3.6 Key Players Placental Stem Cell Therapy Product Solution and Service
3.7 Date of Enter into Placental Stem Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Placental Stem Cell Therapy Breakdown Data by Type
4.1 Global Placental Stem Cell Therapy Historic Market Size by Type (2016-2021)
4.2 Global Placental Stem Cell Therapy Forecasted Market Size by Type (2022-2027)
5 Placental Stem Cell Therapy Breakdown Data by Application
5.1 Global Placental Stem Cell Therapy Historic Market Size by Application (2016-2021)
5.2 Global Placental Stem Cell Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Placental Stem Cell Therapy Market Size (2016-2027)
6.2 North America Placental Stem Cell Therapy Market Size by Type
6.2.1 North America Placental Stem Cell Therapy Market Size by Type (2016-2021)
6.2.2 North America Placental Stem Cell Therapy Market Size by Type (2022-2027)
6.2.3 North America Placental Stem Cell Therapy Market Size by Type (2016-2027)
6.3 North America Placental Stem Cell Therapy Market Size by Application
6.3.1 North America Placental Stem Cell Therapy Market Size by Application (2016-2021)
6.3.2 North America Placental Stem Cell Therapy Market Size by Application (2022-2027)
6.3.3 North America Placental Stem Cell Therapy Market Size by Application (2016-2027)
6.4 North America Placental Stem Cell Therapy Market Size by Country
6.4.1 North America Placental Stem Cell Therapy Market Size by Country (2016-2021)
6.4.2 North America Placental Stem Cell Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Placental Stem Cell Therapy Market Size (2016-2027)
7.2 Europe Placental Stem Cell Therapy Market Size by Type
7.2.1 Europe Placental Stem Cell Therapy Market Size by Type (2016-2021)
7.2.2 Europe Placental Stem Cell Therapy Market Size by Type (2022-2027)
7.2.3 Europe Placental Stem Cell Therapy Market Size by Type (2016-2027)
7.3 Europe Placental Stem Cell Therapy Market Size by Application
7.3.1 Europe Placental Stem Cell Therapy Market Size by Application (2016-2021)
7.3.2 Europe Placental Stem Cell Therapy Market Size by Application (2022-2027)
7.3.3 Europe Placental Stem Cell Therapy Market Size by Application (2016-2027)
7.4 Europe Placental Stem Cell Therapy Market Size by Country
7.4.1 Europe Placental Stem Cell Therapy Market Size by Country (2016-2021)
7.4.2 Europe Placental Stem Cell Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Placental Stem Cell Therapy Market Size (2016-2027)
8.2 Asia-Pacific Placental Stem Cell Therapy Market Size by Type
8.2.1 Asia-Pacific Placental Stem Cell Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Placental Stem Cell Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Placental Stem Cell Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Placental Stem Cell Therapy Market Size by Application
8.3.1 Asia-Pacific Placental Stem Cell Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Placental Stem Cell Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Placental Stem Cell Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Placental Stem Cell Therapy Market Size by Region
8.4.1 Asia-Pacific Placental Stem Cell Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Placental Stem Cell Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Placental Stem Cell Therapy Market Size (2016-2027)
9.2 Latin America Placental Stem Cell Therapy Market Size by Type
9.2.1 Latin America Placental Stem Cell Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Placental Stem Cell Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Placental Stem Cell Therapy Market Size by Type (2016-2027)
9.3 Latin America Placental Stem Cell Therapy Market Size by Application
9.3.1 Latin America Placental Stem Cell Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Placental Stem Cell Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Placental Stem Cell Therapy Market Size by Application (2016-2027)
9.4 Latin America Placental Stem Cell Therapy Market Size by Country
9.4.1 Latin America Placental Stem Cell Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Placental Stem Cell Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Placental Stem Cell Therapy Market Size (2016-2027)
10.2 Middle East & Africa Placental Stem Cell Therapy Market Size by Type
10.2.1 Middle East & Africa Placental Stem Cell Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Placental Stem Cell Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Placental Stem Cell Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Placental Stem Cell Therapy Market Size by Application
10.3.1 Middle East & Africa Placental Stem Cell Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Placental Stem Cell Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Placental Stem Cell Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Placental Stem Cell Therapy Market Size by Country
10.4.1 Middle East & Africa Placental Stem Cell Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Placental Stem Cell Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Lifebank Stem Cell Banking
11.1.1 Lifebank Stem Cell Banking Company Details
11.1.2 Lifebank Stem Cell Banking Business Overview
11.1.3 Lifebank Stem Cell Banking Placental Stem Cell Therapy Introduction
11.1.4 Lifebank Stem Cell Banking Revenue in Placental Stem Cell Therapy Business (2016-2021)
11.1.5 Lifebank Stem Cell Banking Recent Development
11.2 Cynata
11.2.1 Cynata Company Details
11.2.2 Cynata Business Overview
11.2.3 Cynata Placental Stem Cell Therapy Introduction
11.2.4 Cynata Revenue in Placental Stem Cell Therapy Business (2016-2021)
11.2.5 Cynata Recent Development
11.3 Celularity
11.3.1 Celularity Company Details
11.3.2 Celularity Business Overview
11.3.3 Celularity Placental Stem Cell Therapy Introduction
11.3.4 Celularity Revenue in Placental Stem Cell Therapy Business (2016-2021)
11.3.5 Celularity Recent Development
11.4 Athersys
11.4.1 Athersys Company Details
11.4.2 Athersys Business Overview
11.4.3 Athersys Placental Stem Cell Therapy Introduction
11.4.4 Athersys Revenue in Placental Stem Cell Therapy Business (2016-2021)
11.4.5 Athersys Recent Development
11.5 Americord Registry
11.5.1 Americord Registry Company Details
11.5.2 Americord Registry Business Overview
11.5.3 Americord Registry Placental Stem Cell Therapy Introduction
11.5.4 Americord Registry Revenue in Placental Stem Cell Therapy Business (2016-2021)
11.5.5 Americord Registry Recent Development
11.6 ReNeuron Group
11.6.1 ReNeuron Group Company Details
11.6.2 ReNeuron Group Business Overview
11.6.3 ReNeuron Group Placental Stem Cell Therapy Introduction
11.6.4 ReNeuron Group Revenue in Placental Stem Cell Therapy Business (2016-2021)
11.6.5 ReNeuron Group Recent Development
11.7 ReeLabs
11.7.1 ReeLabs Company Details
11.7.2 ReeLabs Business Overview
11.7.3 ReeLabs Placental Stem Cell Therapy Introduction
11.7.4 ReeLabs Revenue in Placental Stem Cell Therapy Business (2016-2021)
11.7.5 ReeLabs Recent Development
11.8 Mesoblast
11.8.1 Mesoblast Company Details
11.8.2 Mesoblast Business Overview
11.8.3 Mesoblast Placental Stem Cell Therapy Introduction
11.8.4 Mesoblast Revenue in Placental Stem Cell Therapy Business (2016-2021)
11.8.5 Mesoblast Recent Development
11.9 Pluristem Therapeutics
11.9.1 Pluristem Therapeutics Company Details
11.9.2 Pluristem Therapeutics Business Overview
11.9.3 Pluristem Therapeutics Placental Stem Cell Therapy Introduction
11.9.4 Pluristem Therapeutics Revenue in Placental Stem Cell Therapy Business (2016-2021)
11.9.5 Pluristem Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Placental Stem Cell Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hematologic Malignancies and Disorders
1.2.3 Congenital Immunodeficiency Disorders
1.2.4 Metabolic Disorders
1.2.5 Neurological Disorders
1.2.6 Others
1.3 Market by Application
1.3.1 Global Placental Stem Cell Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and Specialty Clinics
1.3.3 Clinical Research Organizations
1.3.4 Research Institutes and Academies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Placental Stem Cell Therapy Market Perspective (2016-2027)
2.2 Placental Stem Cell Therapy Growth Trends by Regions
2.2.1 Placental Stem Cell Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Placental Stem Cell Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Placental Stem Cell Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Placental Stem Cell Therapy Industry Dynamic
2.3.1 Placental Stem Cell Therapy Market Trends
2.3.2 Placental Stem Cell Therapy Market Drivers
2.3.3 Placental Stem Cell Therapy Market Challenges
2.3.4 Placental Stem Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Placental Stem Cell Therapy Players by Revenue
3.1.1 Global Top Placental Stem Cell Therapy Players by Revenue (2016-2021)
3.1.2 Global Placental Stem Cell Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Placental Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Placental Stem Cell Therapy Revenue
3.4 Global Placental Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Placental Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Placental Stem Cell Therapy Revenue in 2020
3.5 Placental Stem Cell Therapy Key Players Head office and Area Served
3.6 Key Players Placental Stem Cell Therapy Product Solution and Service
3.7 Date of Enter into Placental Stem Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Placental Stem Cell Therapy Breakdown Data by Type
4.1 Global Placental Stem Cell Therapy Historic Market Size by Type (2016-2021)
4.2 Global Placental Stem Cell Therapy Forecasted Market Size by Type (2022-2027)
5 Placental Stem Cell Therapy Breakdown Data by Application
5.1 Global Placental Stem Cell Therapy Historic Market Size by Application (2016-2021)
5.2 Global Placental Stem Cell Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Placental Stem Cell Therapy Market Size (2016-2027)
6.2 North America Placental Stem Cell Therapy Market Size by Type
6.2.1 North America Placental Stem Cell Therapy Market Size by Type (2016-2021)
6.2.2 North America Placental Stem Cell Therapy Market Size by Type (2022-2027)
6.2.3 North America Placental Stem Cell Therapy Market Size by Type (2016-2027)
6.3 North America Placental Stem Cell Therapy Market Size by Application
6.3.1 North America Placental Stem Cell Therapy Market Size by Application (2016-2021)
6.3.2 North America Placental Stem Cell Therapy Market Size by Application (2022-2027)
6.3.3 North America Placental Stem Cell Therapy Market Size by Application (2016-2027)
6.4 North America Placental Stem Cell Therapy Market Size by Country
6.4.1 North America Placental Stem Cell Therapy Market Size by Country (2016-2021)
6.4.2 North America Placental Stem Cell Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Placental Stem Cell Therapy Market Size (2016-2027)
7.2 Europe Placental Stem Cell Therapy Market Size by Type
7.2.1 Europe Placental Stem Cell Therapy Market Size by Type (2016-2021)
7.2.2 Europe Placental Stem Cell Therapy Market Size by Type (2022-2027)
7.2.3 Europe Placental Stem Cell Therapy Market Size by Type (2016-2027)
7.3 Europe Placental Stem Cell Therapy Market Size by Application
7.3.1 Europe Placental Stem Cell Therapy Market Size by Application (2016-2021)
7.3.2 Europe Placental Stem Cell Therapy Market Size by Application (2022-2027)
7.3.3 Europe Placental Stem Cell Therapy Market Size by Application (2016-2027)
7.4 Europe Placental Stem Cell Therapy Market Size by Country
7.4.1 Europe Placental Stem Cell Therapy Market Size by Country (2016-2021)
7.4.2 Europe Placental Stem Cell Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Placental Stem Cell Therapy Market Size (2016-2027)
8.2 Asia-Pacific Placental Stem Cell Therapy Market Size by Type
8.2.1 Asia-Pacific Placental Stem Cell Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Placental Stem Cell Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Placental Stem Cell Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Placental Stem Cell Therapy Market Size by Application
8.3.1 Asia-Pacific Placental Stem Cell Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Placental Stem Cell Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Placental Stem Cell Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Placental Stem Cell Therapy Market Size by Region
8.4.1 Asia-Pacific Placental Stem Cell Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Placental Stem Cell Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Placental Stem Cell Therapy Market Size (2016-2027)
9.2 Latin America Placental Stem Cell Therapy Market Size by Type
9.2.1 Latin America Placental Stem Cell Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Placental Stem Cell Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Placental Stem Cell Therapy Market Size by Type (2016-2027)
9.3 Latin America Placental Stem Cell Therapy Market Size by Application
9.3.1 Latin America Placental Stem Cell Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Placental Stem Cell Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Placental Stem Cell Therapy Market Size by Application (2016-2027)
9.4 Latin America Placental Stem Cell Therapy Market Size by Country
9.4.1 Latin America Placental Stem Cell Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Placental Stem Cell Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Placental Stem Cell Therapy Market Size (2016-2027)
10.2 Middle East & Africa Placental Stem Cell Therapy Market Size by Type
10.2.1 Middle East & Africa Placental Stem Cell Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Placental Stem Cell Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Placental Stem Cell Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Placental Stem Cell Therapy Market Size by Application
10.3.1 Middle East & Africa Placental Stem Cell Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Placental Stem Cell Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Placental Stem Cell Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Placental Stem Cell Therapy Market Size by Country
10.4.1 Middle East & Africa Placental Stem Cell Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Placental Stem Cell Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Lifebank Stem Cell Banking
11.1.1 Lifebank Stem Cell Banking Company Details
11.1.2 Lifebank Stem Cell Banking Business Overview
11.1.3 Lifebank Stem Cell Banking Placental Stem Cell Therapy Introduction
11.1.4 Lifebank Stem Cell Banking Revenue in Placental Stem Cell Therapy Business (2016-2021)
11.1.5 Lifebank Stem Cell Banking Recent Development
11.2 Cynata
11.2.1 Cynata Company Details
11.2.2 Cynata Business Overview
11.2.3 Cynata Placental Stem Cell Therapy Introduction
11.2.4 Cynata Revenue in Placental Stem Cell Therapy Business (2016-2021)
11.2.5 Cynata Recent Development
11.3 Celularity
11.3.1 Celularity Company Details
11.3.2 Celularity Business Overview
11.3.3 Celularity Placental Stem Cell Therapy Introduction
11.3.4 Celularity Revenue in Placental Stem Cell Therapy Business (2016-2021)
11.3.5 Celularity Recent Development
11.4 Athersys
11.4.1 Athersys Company Details
11.4.2 Athersys Business Overview
11.4.3 Athersys Placental Stem Cell Therapy Introduction
11.4.4 Athersys Revenue in Placental Stem Cell Therapy Business (2016-2021)
11.4.5 Athersys Recent Development
11.5 Americord Registry
11.5.1 Americord Registry Company Details
11.5.2 Americord Registry Business Overview
11.5.3 Americord Registry Placental Stem Cell Therapy Introduction
11.5.4 Americord Registry Revenue in Placental Stem Cell Therapy Business (2016-2021)
11.5.5 Americord Registry Recent Development
11.6 ReNeuron Group
11.6.1 ReNeuron Group Company Details
11.6.2 ReNeuron Group Business Overview
11.6.3 ReNeuron Group Placental Stem Cell Therapy Introduction
11.6.4 ReNeuron Group Revenue in Placental Stem Cell Therapy Business (2016-2021)
11.6.5 ReNeuron Group Recent Development
11.7 ReeLabs
11.7.1 ReeLabs Company Details
11.7.2 ReeLabs Business Overview
11.7.3 ReeLabs Placental Stem Cell Therapy Introduction
11.7.4 ReeLabs Revenue in Placental Stem Cell Therapy Business (2016-2021)
11.7.5 ReeLabs Recent Development
11.8 Mesoblast
11.8.1 Mesoblast Company Details
11.8.2 Mesoblast Business Overview
11.8.3 Mesoblast Placental Stem Cell Therapy Introduction
11.8.4 Mesoblast Revenue in Placental Stem Cell Therapy Business (2016-2021)
11.8.5 Mesoblast Recent Development
11.9 Pluristem Therapeutics
11.9.1 Pluristem Therapeutics Company Details
11.9.2 Pluristem Therapeutics Business Overview
11.9.3 Pluristem Therapeutics Placental Stem Cell Therapy Introduction
11.9.4 Pluristem Therapeutics Revenue in Placental Stem Cell Therapy Business (2016-2021)
11.9.5 Pluristem Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
